COSCIENS Biopharma Inc.
CSCI.TO
TSX
| 06/30/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.89% | -5.89% | -13.14% | 342.42% | -82.77% |
| Total Receivables | 339.94% | 339.94% | -10.20% | 6.21% | -56.19% |
| Inventory | 4,673.44% | 4,673.44% | -3.03% | -98.40% | 4,305.49% |
| Prepaid Expenses | -99.69% | -99.69% | 411.20% | 1,477.78% | -96.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.45% | 6.45% | -14.22% | 176.87% | -73.12% |
|
|
|||||
| Total Current Assets | 6.45% | 6.45% | -14.22% | 176.87% | -73.12% |
| Net Property, Plant & Equipment | 4,143.17% | 4,143.17% | -14.51% | -97.67% | 4,466.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 514.42% | 514.42% | -1.81% | -60.53% | 158.13% |
| Total Assets | 57.41% | 57.41% | -14.11% | 33.89% | -44.11% |
|
|
|||||
| Total Accounts Payable | 49.25% | 49.25% | 28.72% | 754.80% | -- |
| Total Accrued Expenses | 17.93% | 17.93% | 8.94% | 161.70% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 164.29% | 164.29% | -3.75% | -48.49% | 103.40% |
| Total Finance Division Other Current Liabilities | 366.16% | 366.16% | 3.30% | -- | -- |
| Total Other Current Liabilities | 366.16% | 366.16% | 3.30% | -- | -- |
| Total Current Liabilities | 88.46% | 88.46% | 15.68% | 300.61% | -68.99% |
|
|
|||||
| Total Current Liabilities | 88.46% | 88.46% | 15.68% | 300.61% | -68.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1,500.00% | 1,500.00% | -32.77% | -94.28% | 1,898.57% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -6.30% | -6.30% | -4.74% | -- | -- |
| Total Liabilities | 26.54% | 26.54% | 0.01% | 594.54% | -83.28% |
|
|
|||||
| Common Stock & APIC | -92.50% | -92.50% | -23.62% | 2,070.67% | -95.39% |
| Retained Earnings | 100.41% | 100.41% | -1.47% | -8,714.88% | 101.20% |
| Treasury Stock & Other | -97.16% | -97.16% | 2,327.03% | 2,898.86% | -96.67% |
| Total Common Equity | 102.21% | 102.21% | -28.72% | -38.34% | -19.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 102.21% | 102.21% | -28.72% | -38.34% | -19.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 102.21% | 102.21% | -28.72% | -38.34% | -19.95% |
|
|
|||||